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Little is known about the potential role of microRNAs (miRNAs) in the carcinogenesis of gastric
cancer induced by Helicobacter pylori (H. pylori). Here, we showed that microRNA-222 (miR-222)
was up-regulated in H. pylori-infected gastric mucosa and gastric cancer. Ectopic expression of
miR-222 promoted cell proliferation and colony formation in vitro. Mechanistically, we identiﬁed
RECK as a novel target of miR-222, and also conﬁrmed their relationship by the inverse correlation
of mRNA expression ex vivo. Furthermore, we found that RNA interference silencing of RECK can
mimic the oncogenic effects of miR-222. Collectively, H. pylori may function as an initiator in the
process of carcinogenesis by up-regulating miR-222, which further participates in the progression
of cancer by promoting proliferation and inhibiting RECK.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Gastric cancer is the second most widely diagnosed malignancy
and causes about 12% of all cancer-related deaths each year, espe-
cially in China [1]. International Agency for Research on Cancer cat-
egorized Helicobacter pylori as a group 1 carcinogen for gastric
cancer in 1994 [2]. To date, evidence linking H. pylori to gastric can-
cer has continued to accumulate [3,4]. However, the mechanism
involved in the carcinogenesis of gastric cancer induced by H. pylori
remains poorly deﬁned.
MicroRNAs (miRNAs) are small non-coding RNAs, which regu-
late the expression of up to 30% of human genes, either by inhibiting
mRNA translation or inducing its degradation [5]. Accumulating
evidence indicated that miRNAs were possibly crucial to cancer ini-
tiation, progression and treatment outcome [6]. Aberrant miRNAschemical Societies. Published by E
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), mxh95xy@tom.com (X.-H.expression has also been frequently reported in various pathogen
associated tumors such as hepatocarcinoma [7], cervical cancer
[8]. In gastric cancer, a multitude of mis-expressed miRNAs have
been reported, such as ‘onco(genic)-miRs’, miR-27a and miR-21,
and ‘tumor suppressor miRs’, miR-126 and let-7 families [9–12].
However, the exact role of miRNAs in carcinogenesis remains un-
known, especially in H. pylori-associated gastric cancer.
Previously, we used miRNAs microarray to detect the expres-
sion proﬁles of cellular miRNAs during H. pylori infection [13].
Noticeably, the expression level of miR-222 was signiﬁcantly
up-regulated. MiR-222, known as an ‘oncomiR’, is highly up-regu-
lated in a variety of tumors, including thyroid cancer [14], hepato-
carcinoma [15], and melanoma [16], and could be up-regulated by
some pathogens such as Epstein-Barr virus (EBV) [17].
RECK (reversion-inducing cysteine-rich protein with Kazal
motifs), a tumor suppressor gene, inhibits MMPs involved in break-
down of extracellular matrix (ECM), and angiogenesis-namely
MMP-2, MMP-9 and MTP-2, which are known to be involved in
cancer progression [18]. Thus, it has a signiﬁcant effect on carcino-
genesis by limiting angiogenesis and invasion of tumors through
the ECM. In several common cancers, RECK expression is fre-
quently reduced and the level of residual RECK expression in can-
cer tissues correlates with better prognosis [19]. Studies on RECK
gene regulation may therefore yield important insights into the
mechanisms of carcinogenesis.lsevier B.V. All rights reserved.
Fig. 1. miR-222 expression is up-regulated both in response to H. pylori infection and in gastric cancer. (A) The miR-222 expression was assayed in AGS, HGC-27, BGC-823,
SGC-7901 or GES-1 after H. pylori infection for 12 h. (B) Expression of miR-222 in gastric mucosal tissues from H. pylori-positive patients (n = 18) and H. pylori-negative normal
individuals (n = 12). (C) Comparison of expression level of miR-222 between gastric cancer cell lines AGS, HGC-27, BGC-823, SGC-7901, and ﬁve normal gastric mucosa tissue
samples. (D) Comparison of expression level of miR-222 between gastric cancer tissue and normal tissue samples; Relative expression level of miR-222 was determined by
qRT-PCR, and all data were normalized by U6. Data are mean ± S.D. of triplicate samples and are a representative experiment of three separate experiments, ⁄P < 0.05,
⁄⁄P < 0.01.
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involved in H. pylori-associated gastric carcinogenesis. Our objec-
tive was to investigate the expression level of miR-222 in H.
pylori-infected gastric mucosa and in gastric cancer, to explore its
effect on cell proliferation, and to understand its molecular mech-
anism of function as a tumor oncogene.2. Materials and methods
2.1. Cell lines, H. pylori strain and infection model
Human gastric cancer cell line AGS was cultured in Ham F12
(Hyclone) mediumwith 10% fetal bovine serum (FBS). Other gastric
cancer cell lines HGC-27, BGC-823, SGC-7901 and non-malignant
gastric epithelium cell line GES-1 and HEK-293 cells were cultured
in DMEM (Hyclone) with 10% FBS, they were all maintained in a
humidiﬁed incubator containing 5% CO2 at 37 C. The wild-type
H. pylori strains 26,695 was obtained from ATCC and was grown
as previously described [20].
Cells were seeded at 5  106 cells/ﬂask and grown to 80% con-
ﬂuency. Then, the medium was replaced with antibiotic-free med-
ium. H. pylori was added to cells at a multiplicity of infection of
100:1 and cocultured till total RNA was extracted at 12 h after
H. pylori induction.
2.2. Patients and tissue specimens
The gastric mucosal specimens were obtained from 30 patients
undergoing gastroscope examination as described in our previous
study [13]. The gastric cancer tissues and the correspondingnormal tissues were obtained from patients with primary gastric
cancer as described in Supplementary data.
2.3. Quantitative RT-PCR
Quantitative RT-PCR (qRT-PCR) for the mRNA of RECK and miR-
222 were performed by using PrimeScript RT-PCR kits (Takara) and
TaqMan miRNA assays (Ambion) as described [13] (details shown
in Supplementary data).
2.4. Plasmid construct
The construction of Luciferase report vectors and GFP reporter
vectors were performed according to the instructions (details
shown in Supplementary data).
2.5. Luciferase assay and GFP repression experiments
HEK-293 cells were transfected with Luciferase reporter vector
or GFP reporter vector using Lipofectamine 2000 (Invitrogen) (de-
tails shown in Supplementary data).
2.6. Western blot
RECK protein was analyzed by Western blot using RECK mono-
clonal antibody (Abcam) (details shown in Supplementary data).
2.7. Cell proliferation assay and colony formation
Cell proliferation was assessed using Cell Counting Kit-8 (details
shown in Supplementary data).
Fig. 2. Over-expression of miRNA-222 promotes cell proliferation and colony formation in vitro. (A) Fold changes in miR-222 expression are illustrated by qRT-PCR after the
transfection of miR-control, miR-222 mimics or inhibitors at 100 nM for 24 h. (B) Cells transfected with the indicated oligonucleotides at 100 nM for 48 h were subjected with
CCK-8 analysis. (C) Cells transfected with the indicated oligonucleotides at 100 nM were detected with colony formation assay. (D and E) Cells transfected with different
amounts of miR-222 mimics for 48 h were subjected to CCK-8 analysis. (E) Cells transfected with gradually increased quantity of miR-222 mimics were detected with colony
formation assay. Data are representative of at least three independent experiments, ⁄P < 0.05, ⁄⁄P < 0.01.
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for 24 h were plated at low density (100 cells per 6-well plates).
After incubated for 10 days, the cells were ﬁxed and stained with
crystal violet. Foci and colonies containing more than 50 cells were
counted using a microscope.
2.8. siRNA assay
Small interfering RNA (siRNA) targeting RECK and control siRNA
were purchased from Santa Cruz Biotechnology. All siRNA transfec-
tions were performed with Lipofectamine 2000. Cells were trans-
fected with 100 nM siRNA for 48 h.
2.9. Statistical analysis
The results are expressed as mean ± SD. Student’s t test was ap-
plied to analyze the differences between groups. The relationshipbetween the miR-222 and RECK expression was analyzed using
Pearson’s correlation. Statistical analysis was performed with SPSS
software (version 17). Statistically signiﬁcant data are indicated by
asterisks (⁄P < 0.05, ⁄⁄P < 0.01).
3. Results
3.1. miR-222 expression is up-regulated both in response to H. pylori
infection and in gastric cancer
Previously, we found thatH. pylori could inducemiR-222 expres-
sion by microarray [13]. To conﬁrm the microarray data, we re-
examined miR-222 expression in gastric epithelial cells infected
by H. pylori. As shown in Fig. 1A, H. pylori signiﬁcantly increased
miR-222 level in AGS, HGC-27, BGC-823, SGC-7901 and GES-1. To
determine whether miR-222 is up-regulated in H. pylori-infected
gastric tissues, H. pylori-positive samples (n = 18) and H. pylori-
Fig. 3. RECK is a novel target of miRNA-222. (A) Predicted consequential pairing of target 30-UTR region of RECK (wild type or mutated) and miR-222 mature sequence. (B)
HEK-293 cells were transiently cotransfected with luciferase report vectors, and either miR-222 mimics or miR-control. Luciferase activities were normalized to the activity of
Renilla luciferase. (C and D) HEK-293 cells were transfected with the GFP report vectors and either miR-222 mimics or miR-control. (E) Western blots analysis for RECK of AGS
cells transfected with indicated oligonucleotides. Data are representative of at least three independent experiments, ⁄P < 0.05.
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was signiﬁcantly up-regulated in H. pylori-positive patients, with a
3.2-fold increase. These results suggest that H. pylori infection could
induce the expression level of miR-222 in vitro and ex vivo.
Given thatH. pylori infection is considered to be responsible gas-
tric cancers, we hypothesized that the increasing miR-222 upon H.
pylori infection might be associated with gastric cancers. We exam-
ined the miR-222 expression in gastric cancer cell lines AGS, HGC-
27, BGC-823 and SGC-7901 as well as gastric cancer tissues. As
shown in Fig. 1C, all gastric cancer cell lines except HGC-27 ex-
pressed higher levels of miR-222 comparedwith ﬁve normal gastric
mucosa tissues. Furthermore, we compared miR-222 expression
proﬁles between ﬁve pairs of gastric cancer tissues and matched
normal gastric mucosa tissues. In comparison with the adjacentnon-cancerous tissues, miR-222 showed on average 2.3-fold higher
expression in cancer tissues (Fig. 1D). These results suggested that
miR-222 is over-expressed in gastric cancer.
3.2. Over-expression of miRNA-222 promotes cell proliferation and
colony formation in vitro
To testwhethermiR-222 functions as an oncogene,we examined
the effects of miR-222 on gastric cancer cell proliferation. First, we
tested miR-222 expression in transfected AGS and HGC-27 cells
by qRT-PCR (Fig. 2A). At 48 h post-transfection, the effect of miR-
222 over-expression on cell proliferation was evaluated by CCK-8
assay. In AGS or HGC-27 cells, miR-222mimics showed a signiﬁcant
proliferative effect compared with the control group (Fig. 2B). To
Fig. 4. RECK is potentially involved in miR-222-promoted proliferation in gastric cancer cells. (A) AGS cells were transfected with control siRNA (control siR) or RECK siRNA
(RECK siR) at 100 nM for 48 h. The protein levels of RECK were determined byWestern blot analysis. (B) RNAi knockdown of RECK recapitulates the proliferation effect of miR-
222 detected with colony formation assay. (C and D) AGS cells transfected with the indicated oligonucleotides at 100 nM over 72 h were subjected with CCK-8 analysis. (E)
RECK expression was assayed by Western blot over indicated MOI after H. pylori stimulation of AGS cells for 48 h. (F) AGS cells were infected with H. pylori at different MOI for
48 h followed by CCK-8 analysis. Data are representative of at least three independent experiments, ⁄P < 0.05.
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cancer cells, the colony formation assaywas performed. As is shown
in Fig. 2C, the colony number of AGS or HGC-27 cells transfected
with miR-222 mimics was signiﬁcantly higher than those transfec-
ted with control oligonucleotides. Moreover, miR-222 inhibitors
signiﬁcantly reduced cell proliferation (Fig. 2B) and resulted in few-
er colonies (Fig. 2C) in AGS cells, but not in HGC-27 cells. The reason
of the difference may be related to the low basic level of miR-222 in
HGC-27 cells. The dose-dependent effect of miR-222 mimics was
also conspicuous both in the CCK-8 assay (Fig. 2D) and the colony
formation assay (Fig. 2E). These results suggested that miR-222
could be an oncogene.
3.3. RECK is a novel target of miRNA-222
We used TargetScan (version4.2, http://www.targetscan.org/)
to predict the candidate target genes of miR-222. RECK, a tumor
suppressor gene, was found to have a putative miR-222 binding
sites within its 30UTR (Fig. 3A). To validate whether RECK is a bonaﬁde target of miR-222, we generated two luciferase report vectors
that contain the putative miR-222 binding sites within RECK 30UTR
and mutant 30UTR (30MUT). As shown in Fig. 3B, the relative lucif-
erase activity was reduced following cotransfection with miR-222
mimics compared with transfection with miR-222 control. In con-
trast, no change of luciferase was observed in cells transfected with
30MUT constructs or empty vectors. This result was subsequently
conﬁrmed by GFP repression experiments (Fig. 3C and D). Further-
more, transfection of miR-222 mimics decreased RECK expression
in AGS cells at the protein levels (Fig. 3E), suggesting that RECK
expression could be inhibited by miR-222. Together, these results
suggested that RECK is a novel target of miR-222.
3.4. RECK is potentially involved in miR-222-regulated proliferation in
gastric cancer cells
To investigate whether RECK is involved in miR-222-promoted
proliferation, the effect of siRNA on the RECK expression was ﬁrst
examined (Fig. 4A). Then we investigated whether reduction of
Fig. 5. Inverse correlation of miRNA-222 and RECK expression in gastric cancer
tissues ex vivo. (A) The relative mRNA expression of miR-222 and RECK, normalized
with U6 and b-actin, was assessed in 10 specimens of gastric cancer tissues and
matched normal adjacent gastric tissues by qRT-PCR. (B) An inverse correlation of
RECK and miR-222 expression levels was examined (R = 0.849, P = 0.002).
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miR-222 overexpression. The results revealed that RECK siRNA
transfectants displayed obvious increases in the colony number of
AGS cells (Fig. 4B) and had a higher growth curve (Fig. 4C), com-
pared with control siRNA. Notably, the proliferation-promoting ef-
fect of RECK knockdown was similar to that of miR-222
overexpression (Fig. 2B and C). To further prove the RECK depen-
dence of these effects of miR-222, we measured the proliferation
variations induced by miR-222 in AGS cells previously transfected
with RECK siRNA. The aim of this experiment was to study if the
RECK-depleted cellular environment responds tomiR-222 addition.
The results showed that RECK siRNA and miR-222 seemed to co-
operate to additively enhance the growth activity (Fig. 4D).
Next, we examined whether H. pylori infection could induce
RECK protein down-modulation and cell proliferation. As shown
in Fig. 4E, we observed that there was a gradual decrease in the ra-
tio of RECK to b-actin with H. pylori infection as compared to an
uninfected control. Furthermore, H. pylori strains showed a signif-
icant stimulation in AGS cells growth at low MOI (1:1–50:1). How-
ever, treatment of the AGS cells with high MOI (100:1–200:1)
inhibited cell growth at 48 h (Fig. 4F). Given the complexity of H.
pylori infection, virulence factors of H. pylori such as CagA may play
an important role in the disturbance of cellular homeostasis by
stimulation of cell proliferation and induction of apoptosis [21].
These results demonstrate that up-regulated miR-222 by H. pylori
infection may promote gastric cancer cell proliferation potentially
by regulating RECK expression.
3.5. Inverse correlation of miRNA-222 and RECK expression in gastric
cancer tissues ex vivo
To address the biological signiﬁcance of the RECK–miR-222
interaction in gastric cancer, we initially examined RECK and mir-
222 expression levels in 10 sets of gastric cancer tissues and
matched non-cancerous tissues. qRT-PCR analysis showed that
RECK mRNA was reduced by 50% in 6 of 10 tumors (Fig. 5A, top).
As expected, miR-222 levels were commonly elevated in these tu-
mors, with an increase of >3-fold found in 70% of gastric tumors
comparedwith the normal tissues (Fig. 5A, bottom). Using Pearson’s
correlation analysis of RECK–miR-222 mRNA expression, we ob-
tained a statistically signiﬁcant inverse correlation (Fig. 5B,
R = 0.849, P = 0.002). Taken together, these results indicate that
mir-222 expression is inversely correlated with RECK expression
in a subset of primary gastric cancer tissues.4. Discussion
Recently, accumulating evidences indicate that miRNAs may
contribute to gastric cancer pathogenesis [22]. Although miRNA
signatures for gastric cancer have been established, the role of dys-
regulated miRNAs in gastric carcinogenesis by H. pylori is largely
lacking. Analyses of miRNA regulation will provide opportunities
to develop new means for diagnosis and treatment of gastric
cancer.
Consistent with previous ﬁndings [23], we also found that miR-
222 was highly expressed in gastric cancer. The growth potential
was strongly enhanced when miR-222 were over-expressed in gas-
tric cancer cells. Of note, deregulated cell proliferation is a key
mechanism for neoplastic progression [24]. Thus, these results indi-
cate that miR-222 in gastric cancer cells may function as oncogene
by inducing an enhancement of cell proliferation. Recent reports re-
vealed that negative regulation of p27 and p57 by miR-222 might
also contribute to cell proliferation and viability [25,26]. Moreover,
PTEN, as a target of miR-222, might also affect cell proliferation in
gastric cancers [23]. In this report, we identiﬁed that RECKwas a no-
vel target of miR-222.
We provided functional evidence that a reduction of RECK
expression can mimic miR-222 in promoting gastric cancer cells
to proliferate and form colony, suggesting that targeting RECK is a
mechanism by which miR-222 exerts its oncogenic function. RECK
has been reported as a tumor suppressor gene in gastric cancer
and cell lines [27]. In addition, our data show that the down-modu-
lation of RECK protein in H. pylori-infected cells and miR-222
expression inversely correlates with RECK at transcriptional level
in gastric cancer specimens.We believe that this ﬁne-tuning regula-
tory action exerted by miR-222 on the level of RECK expression
might be important in cancer pathogenesis and progression.
H. pylori infection is considered to be an important factor in gas-
tric carcinogenesis. However, its pathogenic mechanism remains
unknown. To date, some miRNAs have been reported to be up-reg-
ulated upon H. pylori infection, such as miR-21, miR-155 and miR-
146a [12,28]. Here, we have shown that expression of miR-222 was
up-regulated upon H. pylori infection and in gastric cancers, imply-
ing that H. pylori infection induces carcinogenesis in the stomach
probably through altering expression of some miRNAs. In conclu-
sion, our data indicates that H. pylori may function as an initiator
in the process of gastric carcinogenesis by increasing miR-222,
which may function as a tumor oncogene to inﬂuence the prolifer-
ation of gastric cancer cells by targeting tumor suppressor RECK.
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